(SUN) Surgical Innovations
Summary
Trade long or short on this share now through an Interactive Investor Spread Bet or CFD
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Headline | Source | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||||||||||||||||||||||||
| Wed 07:00 | RNS |
|||||||||||||||||||||||||||||||||
|
RNS Number : 5499W Surgical Innovations Group PLC 01 February 2012
Surgical Innovations Group plc ("SI" or "the Group") FDA Approval for Logic™ reusable instrument range US contract with Premier healthcare alliance
Surgical Innovations Group plc (AIM:SUN), the designer and manufacturer of creative solutions for minimally invasive surgery, is pleased to announce that it is has received 510(k) clearance from the US Food and Drug Administration ("FDA") for its Logic™ range of reusable instruments and permits the use of the range in the US market. The instruments are compatible with the Group's Logic™ Handles, which already have approval in the US, and are currently used with SI's Resposable™ Logi™Range. Graham Bowland, Chief Executive Officer of the Group, said: "We are delighted to announce the FDA approval of our reusable instruments in the US. The economic drivers away from single use instruments in the US are clear, and our modular instruments are ideally positioned to satisfy current surgical procedure budgets." The Group is also pleased to announce that its US master dealer, SI USA Inc., has been awarded a contract by the Premier healthcare alliance for the sale of the Group's Resposable™ Logi™Range, and Logic™ range of reusable instruments. The contract will run from 1 April 2012 for three years, with the option to extend a further two years upon the agreement of both parties. The contract will provide SI with additional access to hospitals and hospital networks across the US, and replaces previous, but more limited, contracts already held with Premier. Graham Bowland continued: "This latest contract with Premier provides us with much more flexibility in the products we can offer whilst giving us access to hospitals that we were previously unable to approach. This is a very exciting development for the Group and strengthens our position in our largest target market."
For further enquiries: Surgical Innovations Group plc Seymour Pierce Limited Freddy Crossley/ Sarah Jacobs Tel: +44 (0) 20 7107 8000 Corporate Broking David Banks / Jacqui Briscoe www.seymourpierce.com The Communications Portfolio
Notes to Editors: About Surgical Innovations Group plc Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery (MIS) and industrial markets. As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio. Over 140 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards. The Group's patented products are sold through three main channels:
For more information, see www.sigroupplc.com
About the Premier healthcare alliance,
Premier is a performance improvement alliance of more than 2,500 U.S. hospitals and 80,000-plus other healthcare sites using the power of collaboration to lead the transformation to high quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington.
For more information, see http://www.premierinc.com
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||||||||||||||||||
| 23-01-12 | RNS |
|||||||||||||||||||||||||||||||||
|
RNS Number : 9672V Surgical Innovations Group PLC 23 January 2012
Surgical Innovations Group plc ("SI" or "the Group") Trading update
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery, is pleased to provide the following trading update.
During the year to 31 December 2011 the Group has traded in line with market expectations.
In difficult market conditions SI continued to trade according to plan in the second half of 2011, with a strong fourth quarter. The focus towards development of US opportunities is a major element of the company's strategy, particularly with the current challenges throughout the European market. Orders from the US have continued to grow as a result of strengthened routes to market complementing our Master Dealer's growing distribution network.
The Group has continued to see positive results from its investment program in product development; sales of the innovative PretzelFlex™ laparoscopic retractor have been encouraging following its launch in November. In addition, new handle technology with improved ergonomics for an OEM customer will soon be undergoing clinical evaluations in preparation for launch in the US market.
The concept and development teams have benefited from support from our Clinical Advisory Board, which has been strengthened by three new appointments this month from the fields of general surgery and arthroscopy. We have made advances with our arthroscopy project, and the Group is targeted to introduce a number of new pre-production products at an international arthroscopic clinical congress in the second half of 2012.
The senior management and finance team was strengthened following the appointment of Mike Thornton, formerly a partner at PricewaterhouseCoopers, as Financial Director of Surgical Innovations Limited in December. Mike, who reports directly to Graham Bowland and the Group Board, has already made a positive impact.
Graham Bowland, Chief Executive Officer, said: "SI has made progress in 2011, particularly in the US and in the development and launch of new products. The Group looks forward with confidence."
Preliminary results for the year to 31 December 2011 are expected to be released on 24 April 2012. - Ends - For further enquiries: Surgical Innovations Group plc Seymour Pierce Limited Freddy Crossley/ Sarah Jacobs Tel: +44 (0) 20 7107 8000 Corporate Broking David Banks / Jacqui Briscoe www.seymourpierce.com The Communications Portfolio
Notes to Editors: About Surgical Innovations Group plc Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery (MIS) and industrial markets. As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio. Over 140 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards. The Group's patented products are sold through three main channels:
For more information, see www.sigroupplc.com
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||||||||||||||||||
| 02-12-11 | RNS |
|||||||||||||||||||||||||||||||||
|
RNS Number : 2145T Surgical Innovations Group PLC 02 December 2011
Surgical Innovations Group plc ("SI" or "the Group") Investor site visit
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, will today be hosting an investor site visit at its manufacturing facility in Leeds. No new trading or financial information will be disclosed during the visit.
-Ends-
For further enquiries: Surgical Innovations Group plc Seymour Pierce Limited Corporate Broking The Communications Portfolio
Notes to Editors: About Surgical Innovations Group plc Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery (MIS) and industrial markets. As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio. Over 140 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards. The Group's patented products are sold through three main channels:
For more information, see www.surginno.com
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||||||||||||||||||
| 03-11-11 | RNS |
|||||||||||||||||||||||||||||||||
|
RNS Number : 4025R Surgical Innovations Group PLC 03 November 2011
Surgical Innovations Group plc ("SI" or "the Group") Issue of Equity
Surgical Innovations Group plc (AIM:SUN), the designer and manufacturer of innovative medical devices, today announces that following the exercise of options by an employee it has issued and allotted 330,000 ordinary shares with an exercise price of 3.5p each on 2 November 2011. Accordingly Application has been made to the London Stock Exchange for the 330,000 New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that such Admission will occur on 9 November 2011. The new ordinary shares rank pari passu with the existing shares of the Company.
Following Admission the total number of ordinary shares in issue will be 395,202,902 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the purposes of the Disclosure and Transparency Rules. - Ends - Enquiries:
Notes to Editors: About Surgical Innovations Group plc Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery (MIS) and industrial markets. As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio. Over 140 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards. The Group's patented products are sold through three main channels:
For more information, see www.surginno.com
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||||||||||||||||||
| Result Pages: 1 | ||||
| Date/Time | Subject | Author | ||
|---|---|---|---|---|
| Tue 21:15 | ||||
|
|
||||
|
|
||||
|
Tuesday, Feb 07 2012 by Hybridan
http://bit.ly/xWqtBQ |
||||
| Tue 11:13 | ||||
|
|
||||
|
|
||||
|
|
||||
| Fri 21:51 | ||||
|
|
||||
|
|
||||
|
There is a simple 2 word response. the 2nd word is off.
|
||||
| Thu 16:03 | ||||
|
|
||||
|
|
||||
|
k don. This is a repeat of what happened last year in the run up to results. Its a total scam and SI reported on their website for investors to beware!
|
||||
|
|
||||
They have not been approved or issued by Interactive Investor Trading Limited.
Editor's Pick:
Am I in danger of losing half of my money?Editor's Pick:
Cruise-onomics: Is the stock as cheap as the trip?Editor's Pick:
AIM diamond miners refuse to sparkleEditor's Pick:
Stock to Watch: Imperial TobaccoEditor's Pick:
George Godber’s AIM stock picks

